Scientific Literature Search

Source record

Progress in diagnosis and treatment of Parkinson's disease and clinical application and prospect of acupuncture and moxibustion treatment.

Qi B, Wen QR, Zhai LY.

Front Med (Lausanne) · 2026-09-22

DOI: 10.3389/fmed.2026.1842383PMID: 42840214

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Open access

Convergent Astrocytic Failure in Parkinson's Disease: A System-Level Model of Pathogenesis and Treatment.

Abdelaziz AM, Fawzy MN, Shokr MM.

Mol Neurobiol · 2026-09-22

DOI: 10.1007/s12035-026-06177-0PMID: 42768228

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Dysregulated polyamine metabolism in neurological disorders: molecular mechanisms and therapeutic opportunities.

Li K, Si Q, Zhang C, Zhang C, Wang M, Liu J, Zhao J, Xing H, Liu J.

Mol Biol Rep · 2026-09-22

DOI: 10.1007/s11033-026-12774-yPMID: 42771220

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Open access

Real-world neuropsychiatric safety profile of foslevodopa/foscarbidopa infusion in advanced Parkinson's disease.

Lazzeri G, Zangaglia R, Fazio C, Contaldi E, Bonvegna S, Regalbuto S, Malaspina S, Pezzoli G, Jelmoni AJM, Piazza S, Valentino F, Magistrelli L, Isaias IU, Pisani A.

J Neurol · 2026-09-21

DOI: 10.1007/s00415-026-14113-4PMID: 42766028

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Phytogenic Nanoparticles for Parkinson's Disease Therapy: Mechanistic Insights, Brain-Targeted Delivery and Neuroprotective Potential.

Khatiwara D, Sarma S, Pathak M, Sangroula S, Sahariah BJ, Deka MK, Das AK.

Mol Neurobiol · 2026-09-21

DOI: 10.1007/s12035-026-06218-8PMID: 42766050

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Open access

Long-Term Clinical Efficacy, Safety, and Polypharmacy Simplification of Levodopa-Entacapone-Carbidopa Intestinal Gel in Advanced Parkinson's Disease: An 18-Month Longitudinal Study.

Orbán-Kis K, Szatmári S, Constantin VA, Szász RM, Bățagă S, Szederjesi J, Ciorba M, Nagy EE, Neagoe RM, Kelemen K, Bíró K, Ciorba Nicoleta C, Mihály I, Frigy A, Szász JA.

J Clin Med · 2026-09-21

DOI: 10.3390/jcm15187319PMID: 42796091

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Open access

Utilizing a <i>Drosophila</i> Larval Model of Synucleopathy to Explore Mushroom Extract Treatments for Parkinson's Disease.

Perry S, Davis F, Patel V, Alvarado R, Black M, Bretanys Desca J, Briggs M, Buck J, Campbell J, Carter E, Clark D, Collins A, Curtis C, Denker S, Gillard M, Goldammer L, Gorman T, Grayson C, Heller D, Holmes Cerveny K, Izaguirre J, James C, Jeffries K, Johnson S, Keeler E, Kincade P, Lambert E, Malagon D, Marks E, Mcgeshick J, McKinney S, Melendrez Z, Mignano G, Miller J, Miller H, Perales J, Pun C, Rollet T, Ross S, Rourke D, Ryan C, Slinker C, Spann-Mcdonald Z, Spurk J, Steele M, Sylvester E, Turpen S, Upshaw T.

MicroPubl Biol · 2026-09-19

DOI: 10.17912/micropub.biology.002349PMID: 42830874

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Cell Therapy Targeting Pathological Networks in Neurodegenerative Diseases: Mechanisms and Translation from Stem Cells to Extracellular Vesicles.

Duan X, Li Y, Zhao R, Jiang X, Xia C, Xie F.

Curr Neurovasc Res · 2026-09-18

DOI: 10.2174/0115672026476083260903180127PMID: 42770444

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Efficacy and Safety of Inhaled and Sublingual Apomorphine for On‑Demand Treatment of OFF Episodes in Parkinson Disease: A Systematic Review and Meta-Analysis With Exploratory Network Comparison.

Pitton Rissardo J, Vargas Rojas JL, Aristizabal Marin J, Fornari Caprara AL.

Clin Neuropharmacol · 2026-09-17

DOI: 10.1097/wnf.0000000000000706PMID: 42757652

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Open access

New approach methodologies in neurotherapeutics development.

Tamiz AP, Baran SW, Hartung T, Wu WW.

Neurotherapeutics · 2026-09-17

DOI: 10.1016/j.neurot.2026.e01056PMID: 42753291

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Genomic and transcriptomic quality control for an autologous iPSC-derived cell therapy for Parkinson's disease.

Bratt-Leal AM, Gorba T, Williams RM, Mossman JA, Hills R, Tran H, Barken D, Beauvais G, Fremgen D, Zhang A, Pivaroff C, Lynch C, Liu Y, Chandrasekaran C, Tastad D, Bridge C, Wakeman DR, Nguyen U, Chamberlain B, Lane EL, Lelos MJ, Loring JF, Wirth ED, Zhang X.

Cell Stem Cell · 2026-09-17

DOI: 10.1016/j.stem.2026.08.014PMID: 42753738

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Repurposing Anticancer Drugs in Parkinson's Treatment: Molecular Pathways Driving Neuroprotection and Therapeutic Advancement.

Bedage PL, Dhanush Y, Chettri P, Shivakumar, Ahmed SS, Raghunathanaidu BD.

Mol Neurobiol · 2026-09-16

DOI: 10.1007/s12035-026-06207-xPMID: 42747624

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

20.463 articles found

Progress in diagnosis and treatment of Parkinson's disease and clinical application and prospect of acupuncture and moxibustion treatment.

Convergent Astrocytic Failure in Parkinson's Disease: A System-Level Model of Pathogenesis and Treatment.

Dysregulated polyamine metabolism in neurological disorders: molecular mechanisms and therapeutic opportunities.

Real-world neuropsychiatric safety profile of foslevodopa/foscarbidopa infusion in advanced Parkinson's disease.

Phytogenic Nanoparticles for Parkinson's Disease Therapy: Mechanistic Insights, Brain-Targeted Delivery and Neuroprotective Potential.

Long-Term Clinical Efficacy, Safety, and Polypharmacy Simplification of Levodopa-Entacapone-Carbidopa Intestinal Gel in Advanced Parkinson's Disease: An 18-Month Longitudinal Study.

Utilizing a <i>Drosophila</i> Larval Model of Synucleopathy to Explore Mushroom Extract Treatments for Parkinson's Disease.

Cell Therapy Targeting Pathological Networks in Neurodegenerative Diseases: Mechanisms and Translation from Stem Cells to Extracellular Vesicles.

Efficacy and Safety of Inhaled and Sublingual Apomorphine for On‑Demand Treatment of OFF Episodes in Parkinson Disease: A Systematic Review and Meta-Analysis With Exploratory Network Comparison.

New approach methodologies in neurotherapeutics development.

Genomic and transcriptomic quality control for an autologous iPSC-derived cell therapy for Parkinson's disease.

Repurposing Anticancer Drugs in Parkinson's Treatment: Molecular Pathways Driving Neuroprotection and Therapeutic Advancement.

Filters